ACTUALIZACIÓN DE LA CLÍNICA, EL DIAGNÓSTICO Y EL TRATAMIENTO DEL LINFOMA RENAL PRIMARIO
Con el artículo se pretende realizar revisión actualizada sobre el origen, epidemiología, características clínicas, diagnóstico, pronóstico y especialmente del tratamiento del linfoma renal primario. Aunque no existe una terapia estándar dado el bajo número de casos, se revisan los resultados de tratamiento basados en quimioterapia con rituximab descritos en artículos recientes.
Institución del autor
Hospital Universitario Virgen de las Nieves, Granada, España
Coautores
Ignacio Puche Sanz* José Flores Martín* Francisco Javier Vicente Prados* Juan Manuel Cózar Olmo* Carolina Sánchez Ramos*
Hospital Universitario Virgen de las Nieves, Granada, España*
Palabras clave
neoplasia renal, linfoma renal primario, rituximab
Bibliografía del caso clínico
1. Coggins CH. Renal failure in lymphoma. Kidney Int 17:847-855, 1980.
2. Stallone G, Infante B, Manno C et al. Primary renal lymphoma does exist: case report and review of the literature. J Nephrol 13:367-372, 2000.
3. Malbrain ML, Lambrecht GL, DAELEMANS R et al. Acute renal failure due to bilateral lymphomatous infiltrate. Primary extranodal non-Hodgin's lymphoma (p-EN-NHL) of the kidneys: does it really exist?. ClinNephrol 42:163-169, 1994.
4. Okuno SH, Hoyer JD, Ristow K et al. Primary renal non-Hodgkin's lymphoma. An unusual extranodal site. Cancer 75(9):2258-2261, 1995.
5. Tefekli A, Baykal M, Binbay M. et al. Lymphoma of the kidney: primary or initial manifestation of rapidly progressive systemic disease? Int Urol Nephrol 38(3-4): 775-778, 2006.
6. Barreto F, DALL'OGLIO MF, SROUGI M. Renal lymphoma. Atypical presentation of a renal tumor. Int Braz J Urol 32, 2006.
7. Venizelos ID, Rombis V, Tulupidis, S et al. Primary anaplastic large cell lymphoma of the kidney. Leuk Lymphoma 44(2):353-355, 2003.
8. Brouland JP, Meeus F, Rossert J. et al. Primary bilateral B-cell renal lymphoma: a case report and review of the Literature. Am J Kidney Dis 24:586-589, 1994.
9. Torrecilla García-Ripoll JR, Pascual Samaniego M, Martín Blanco, S et al. Primary renal lymphoma. Actas Urol Esp 27(7):555-558, 2003.
10. Duanay PN. Linfosarcoma y linfosarcomatosis de los riñones: part II. Rev Med Trop Parasitol Bacterial Clin Lab 6:213, 1940.
11. Freire J, López Vázquez AM, Castro I et al. Insuficiencia renal aguda por linfoma de Burkitt renal primario bilateral. An Pediatr (Barc) 73(4):199-201, 2010.
12. Ahmad AH, MacLennan GT, Listinsky C. Primary renal lymphoma: a rare neoplasm that may present as a primary renal mass. J Urol 173(1):239, 2005.
13. Sebastian Montal L, Batalla Cadira JL, Delas Amat J. Primary renal lymphoma. A propos of a case. Arch Esp Urol 51(2):180-182, 1998.
14. Gellrich J, Hakenberg OW, Naumann, R et al. Primary renal non-Hodgkin's lymphoma - a difficult differential diagnosis. Onkologie 25(3):273-277, 2002.
15. Choi JH, Choi GB, SHIM KN et al. Bilateral primary renal non-Hodgkin's lymphoma presenting with acute renal failure: successful treatment with systemic chemotherapy. Acta Haematol 97(4):231-235, 1997.
16. Zahner J, Gerharz CD, Bach D et al. Association of primary renal non-Hodgkin's lymphoma with mesangioproliferative glomerulonephritis. Am J Hematol 53(2):126-132, 1996.
17. Urban Bruce A, Fishman Elliot K, Renal lymphoma: CT patterns with emphasis on helical CT. RadioGraphics 20:197-212, 2000.
18. Cyriac S, Rejiv R, Shirley, S et al. Primary renal lymphoma mimicking renal cell carcinoma. Indian J Urol 26(3):441-443, 2010.
19. Sharma SK, Hemal AK, Goswami AK et al. Primary renal Hodgkin's lymphoma: case report. Urol Int 44(5):313-315, 1989.
20. Niitsu N, Okamura D, Takahashi N et al. Renal intravascular large B-cell lymphoma with early diagnosis by renal biopsy: a case report and review of the literature. Leukemia Reserch 33:728-730, 2009.
21. Kameoka Y, Takahashi N, Komatsuda A et al. Kidney-limited intravascular large B cell lymphoma: a distinct variant of IVLBCL? Int J Hematol 89(4):533-537, 2009.
22. Sawa N, Ubara Y, Katori H et al. Renal intravascular large B-cell lymphoma localized only within peritubular capillaries Report of a case. Intern Med 46(10):657-662, 2007.
23. Tirelli U, Errante D, van Glabbeke M et al. CHOP is the standard regimen in patients > or > 70 years of age with intermediate-grade and high grade non Hodgkin's lymphoma: results of a randomized study of the European Organization of Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 16(1):27-34, 1998.
24. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 346(4):235-242, 2002.
25. Shimada K, Matsue K, Yamamoto et al. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemoterapy as reported by the IVL study group in Japan. J Clin Oncol 26:3189-3195, 2008.
26. Lin TY, Zhang HY, Huang H et al. Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China: a multi-center randomized trail. Zheng 24(12):1421-1426, 2005.
27. Morita Y, Matsuda M, Yamaguchi T et al. Efficacy of rituximab monotheraphy for an elderly hemodialysis patient with primary cardiac lymphoma. Inter Med 49:2163-2166, 2010.
28. Nakagawa Y, Ikeda U, Hirose M et al. Succesful treatment of primary cardiac lymphoma with monoclonal CD20 antibody rituximab. Circ J 68:172-173, 2004.
29. Diskin CJ, Stokes TJ, Dansby LM et al. Acute renal failure due to a primary renal B-cell lymphoma. Am J Kidney Dis 50(5):885-889, 2007.
30. Maloney DG, Grillo-López AJ, WHITE TA et al. IDEC C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low grade non-Hodgking's lymphoma. Blood 90:1188-1195, 1994.
31. Tokar M, Rogachev B, Levi I. et al. Rituximab in a patient with acute renal failure due to B-cell lymphomatous infiltration of the kidneys. Leuk Lymphoma 45(4):819-820, 2004.
32. Ginaldi L, De MM, Matutes E et al. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. Journal of Clinical Pathology 51:364-369, 1998.
33. Butterly SJ, Pillans P, Horn B et al. Off-label use of rituximab in a tertiary Queensland Hospital. Internal Medicine Journal 40:443-452, 2010.
34. Brodt P, Gordon J. Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor. J Immunol 121:359-362, 1978.
35. Aklilu M, Stadler WM, Markiewicz, M et al. Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma. Annals of Oncology 15:1109-1114, 2004.
36. Mc Donald V, Leandro M. Rituximab in non-haematological disorders of adults and its mode of action. British Journal of Haematology 146:233-246, 2009.
37. Becker YT, Becker BN, Pirsh JD et al. Rituximab as treatment for refractory kidney transplant rejection. American Journal of Transplantation 4:996-1001, 2004.
38. Belbaraka R, Elyoubi MB, Boutayeb S et al. Primary renal non-Hodgkin lymphoma: an unusual diagnosis for a renal mass. Indian J Cancer 48:255-256, 2011.
39. Vázquez-Alonso F, Sánchez C, Vicente FJ et al. Primary renal lymphoma: report of three new cases and literature review. Arch Esp Urol 62(6):461-465, 2009.
Artículos publicados por el autor
(selección)
Resultado a largo plazo de la uretroplastia término-terminal. Actas Urol Esp 29(29):499-505, 2005
Metástasis suprarrenal metacrónica en 2 pacientes sometidos a nefrectomía radical por carcinoma de células renales primario. Arch Esp 59(59):779-84., 2006
Uretroplastia dorsal con injerto libre de mucosa prepucial (Técnica de Bargagli): resultados preliminares de nuestra serie. Arch Esp 59(59):859-66., 2006
Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma. Tissue Antigens 68(68):303-10, 2006
Tumor testicular metacrónico secundario a carcinoma vesical infiltrante. Arch Esp Urol 60(60):81-3., 2007
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los
contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin
previo y expreso consentimiento de SIIC.